Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
265,214,861
Total 13F shares
2,521
Share change
-36,485
Total reported value
$6,202
Price per share
$2.46
Number of holders
2
Value change
-$145,440
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
CBC Investment I-Mab Ltd
13D/G
Wei Fu
12%
30,499,709
$121,227,193 +$11,952,376 29 Jan 2026
Everest Medicines Ltd
13D/G
Everest Medicines Limited
16%
42,524,716
$90,577,645 $0 05 Aug 2025
JANUS HENDERSON GROUP PLC
13F
Company
3.2%
8,436,641
$33,577,831 31 Dec 2025
13F
HHLR ADVISORS, LTD.
13F
Company
2.3%
5,980,568
$23,802,661 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
1.4%
3,785,502
$15,066,298 31 Dec 2025
13F
Siren, L.L.C.
13F
Individual
1.1%
3,000,000
$11,940,000 31 Dec 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.87%
2,298,501
$9,148,034 31 Dec 2025
13F
Ariose Capital Management Ltd
13F
Company
0.51%
1,363,515
$5,426,790 31 Dec 2025
13F
S.c.a. Candriam
13F
Individual
0.43%
1,132,563
$4,507,793 31 Dec 2025
13F
Woodline Partners LP
13F
Company
0.4%
1,050,000
$4,179,000 31 Dec 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.38%
1,000,000
$3,980,000 31 Dec 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.32%
846,008
$3,367,112 31 Dec 2025
13F
BARCLAYS PLC
13F
Company
0.24%
628,923
$2,503,113 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
0.23%
618,347
$2,461,021 31 Dec 2025
13F
Exome Asset Management LLC
13F
Company
0.19%
499,587
$1,988,356 31 Dec 2025
13F
AIHC Capital Management Ltd
13F
Company
0.16%
413,979
$1,647,636 31 Dec 2025
13F
STATE STREET CORP
13F
Company
0.14%
359,878
$1,432,314 31 Dec 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.07%
191,714
$763,022 31 Dec 2025
13F
UBS Group AG
13F
Company
0.07%
181,776
$723,468 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
148,452
$590,839 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
140,946
$560,965 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
0.05%
140,867
$560,651 31 Dec 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.05%
131,830
$524,683 31 Dec 2025
13F
Taikang Asset Management (Hong Kong) Co Ltd
13F
Company
0.05%
128,765
$512,485 31 Dec 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.04%
116,705
$464,486 31 Dec 2025
13F
ALPS ADVISORS INC
13F
Company
0.04%
112,451
$447,555 31 Dec 2025
13F
DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.
13F
Company
0.03%
80,400
$319,992 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
47,479
$188,966 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
45,084
$179,434 31 Dec 2025
13F
SG Americas Securities, LLC
13F
Company
0.01%
36,481
$145,000 31 Dec 2025
13F
NOMURA HOLDINGS INC
13F
Company
0.01%
35,200
$140,096 31 Dec 2025
13F
Squarepoint Ops LLC
13F
Company
0.01%
34,322
$136,602 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
32,581
$129,673 31 Dec 2025
13F
Quadrature Capital Ltd
13F
Company
0.01%
29,588
$117,760 31 Dec 2025
13F
MANGROVE PARTNERS IM, LLC
13F
Company
0.01%
26,026
$103,583 31 Dec 2025
13F
Leonteq Securities AG
13F
Company
0.01%
21,000
$83,580 31 Dec 2025
13F
Invesco Ltd.
13F
Company
0.01%
20,403
$81,204 31 Dec 2025
13F
China Universal Asset Management Co., Ltd.
13F
Company
0.01%
16,940
$67,421 31 Dec 2025
13F
Brooklyn Investment Group
13F
Company
0%
12,715
$51,242 31 Dec 2025
13F
Freestone Capital Holdings, LLC
13F
Company
0%
10,000
$39,800 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
8,219
$32,711 31 Dec 2025
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0%
7,583
$30,180 31 Dec 2025
13F
ROYAL BANK OF CANADA
13F
Company
0%
6,360
$25,000 31 Dec 2025
13F
CITIGROUP INC
13F
Company
0%
6,039
$24,035 31 Dec 2025
13F
GROUP ONE TRADING LLC
13F
Company
0%
3,963
$15,773 31 Dec 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0%
3,060
$12,178 31 Dec 2025
13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
13F
Company
0%
2,947
$11,729 31 Dec 2025
13F
GF FUND MANAGEMENT CO. LTD.
13F
Company
0%
2,042
$8,127 31 Dec 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,765
$7,025 31 Dec 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
1,104
$4,394 31 Dec 2025
13F

Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2026

As of 31 Mar 2026, NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,521 shares. The largest 2 holders included GF FUND MANAGEMENT CO. LTD. and Vermillion Wealth Management, Inc.. This page lists 2 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
57
Q1 2026 holders
2
Holder diff
-55
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.